Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: A new technique to.

Slides:



Advertisements
Similar presentations
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Advertisements

Of mice and men and surgical transcatheter aortic valve insertion
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation?  Christos G. Mihos, DO, Orlando Santana,
Hans-Hinrich Sievers, MD 
Ground glass opacity of the lung: The veil that needs lifting
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Abracadabra I, II…HeartMate 3?
Form ever follows function
William M. DeCampli, MD, PhD 
How should we treat air leaks?
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.
Bicuspid aortic valve aortopathy: One size fits all?
Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 
The lord of the rings  Antonio Miceli, MD, PhD 
The variability of the mitral valve anatomy and terminology
Support Your Specialty
Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Fixing the supply problem
Hans-Hinrich Sievers, MD 
Military surgeons just want to have fun
The first self-endothelialized titanium-coated glutaraldehyde-fixed heart valve prosthesis within systemic circulation  Norbert W. Guldner, MD, Inka Jasmund,
Torsten Doenst, MD, PhD, Markus Richter, MD 
The Journal of Thoracic and Cardiovascular Surgery
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Michael Lanuti, MD  The Journal of Thoracic and Cardiovascular Surgery 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Niv Ad, MD, Lawrence M. Wei, MD 
Daniel T. Engelman, MD, FACS, Michael J. Germain, MD 
The Journal of Thoracic and Cardiovascular Surgery
Replicating the success of mitral valve repair in the aortic valve
Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry  Daniel J.P. Burns, MD, MPhil  The Journal of.
Commentary: Do the right thing! Ethical versus legal
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Sutureless valve implantation: Every detail counts
Biomaterials for heart valve replacement: Conjectures and refutations
Michael Mack, MD  The Journal of Thoracic and Cardiovascular Surgery 
Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD 
Shunt right or left? Decision 2016
Functional tricuspid pathology: To treat or not to treat
Warfarin or aspirin after mitral valve repair: Why work harder?
Hans-Joachim Schäfers, MD 
The harder one looks, the more one finds
First nights, the adrenal axis, and steroids
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Apparently, size matters…in congenital heart disease and brain injury
Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable  Craig M. Jarrett,
The continuing challenge of congenital heart disease in China
External tracheal stenting for pediatric airway obstruction: A word of caution  Roosevelt Bryant, MD  The Journal of Thoracic and Cardiovascular Surgery 
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10%  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular.
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
Toward a more rational approach in treating type B aortic dissection
Evaluating the best approach to treatment of aortic stenosis: The jury is still out  Glen B. Taksler, PhD  The Journal of Thoracic and Cardiovascular Surgery 
First in line for robotic surgery: Would you want to know?
Apples remain apples NO matter what
Preoperative PFTs: The answer is blowing in the wind
The evolution of cardiothoracic critical care
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Journal changes and initiatives
Edward Y. Chan, MD, Michael J. Reardon, MD 
Presentation transcript:

Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: A new technique to improve biologic heart valve prosthesis durability?  Norbert W. Guldner, MD, Fabienne Bastian, MD, Günther Weigel, MD, Hanngörg Zimmermann, MS, Markus Maleika, MS, Michael Scharfschwerdt, MS, Daniel Rohde, MS, Hans-Hinrich Sievers, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 143, Issue 5, Pages 1152-1159 (May 2012) DOI: 10.1016/j.jtcvs.2011.10.076 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 A, Scanning electron microscopy of glutaraldehyde (GA)-fixed pericardium with a magnification of 5000×; B, GA-fixed and dehydrated pericardium; and C, GA-fixed and dehydrated and titanized pericardium, with complete covering of surface by titanium. D, Rehydrated and swollen titanized pericardium with a fractured titanium coat and grooves. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 1152-1159DOI: (10.1016/j.jtcvs.2011.10.076) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Immunostaining of iC3b deposits on (A) glutaraldehyde (GA)-fixed pericardium; (B) GA-fixed pericardium with 10% citric acid (CA10%); and (C) GA-fixed pericardium with CA10%, aldehyde-dehydrogenase, and plasma treatment, D is similar to C but additionally with a titanium coating. D and E, Principle of iC3b quantification with marking of the iC3b-related red pixels (see “Materials and Methods” section) and deleting the counted pixels (white) for control (F). The Journal of Thoracic and Cardiovascular Surgery 2012 143, 1152-1159DOI: (10.1016/j.jtcvs.2011.10.076) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Titanium coating of glutaraldehyde (GA)-fixed pericardium in group 4 reduced the immune reaction of iC3b apposition on the collagen surface to 38.49% (P < .043). Group 3 was treated with 10% citric acid (CA10%), aldehyde-dehydrogenase, and a physical plasma without titanium. These findings indicate that titanization of blood-contacting surfaces might significantly reduce the immunologic response to iC3b (apposition of iC3b in group 4 might be even <38% without CA10% application). The Journal of Thoracic and Cardiovascular Surgery 2012 143, 1152-1159DOI: (10.1016/j.jtcvs.2011.10.076) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 IC3b-activated polymorphonuclear (PNM) leukocytes on and in front of glutaraldehyde (GA)-fixed pericardium (group 1), GA-fixed pericardium with 10% citric acid (CA10%) (group 2), GA-fixed pericardium with CA10%, aldehyde-dehydrogenase, and plasma treatment (group 3), group 4 is similar to group 3 but additionally with a titanium coating. On these photographs of the titanium-coated group 4, PNM leukocytes are visible solely in samples 2 and 4. However, on average, they showed a decrease in PNM leukocytes of 6.3% (P ≤ .01). The Journal of Thoracic and Cardiovascular Surgery 2012 143, 1152-1159DOI: (10.1016/j.jtcvs.2011.10.076) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Titanium coating of GA-fixed pericardium in group 4 reduced attraction of polymorphonuclear (PNM) leukocytes to 6.0% (P ≤ .05). Group 3 was treated with 10% citric acid (CA10%), aldehyde-dehydrogenase, and physical plasma without titanium. These findings indicate that titanization of blood-contacting surfaces might significantly also reduce activation and attraction of PNM leukocytes. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 1152-1159DOI: (10.1016/j.jtcvs.2011.10.076) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

The Journal of Thoracic and Cardiovascular Surgery 2012 143, 1152-1159DOI: (10.1016/j.jtcvs.2011.10.076) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions